Adage Capital Partners Gp, L.L.C. Wave Life Sciences Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 12,516,500 shares of WVE stock, worth $82 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
12,516,500
Previous 9,622,104
30.08%
Holding current value
$82 Million
Previous $119 Million
15.03%
% of portfolio
0.2%
Previous 0.22%
Shares
13 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$119 Million3.05% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$54.1 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$44.1 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$41.6 Million0.56% of portfolio
-
M28 Capital Management LP Stamford, CT5.66MShares$37.1 Million48.34% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $569M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...